New 2024 TrialWire Logo (600 x 500 px) (400 x 100 px) (600 x 200 px) (3).png
TrialWire Patient Recruitment Platform that Reboots Stalled Clinical Trials announced as Multi-Award Finalist in the 2024 Citeline Awards
May 12, 2024 16:29 ET | TrialWire
The TrialWire™ Rapid Patient Recruitment Platform, the only pay-per-enrolled fixed-fee solution powered by AI and algorithms, has been select for 3 awards
SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Intel Corporation - INTC
May 12, 2024 16:29 ET | Pomerantz LLP
NEW YORK, May 12, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Intel Corporation (“Intel” or the “Company”) (NASDAQ: INTC).   Such investors...
SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Equinix, Inc. – EQIX
May 12, 2024 16:28 ET | Pomerantz LLP
NEW YORK, May 12, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Equinix, Inc. (“Equinix” or the “Company”) (NASDAQ: EQIX). Such investors are...
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Wolfspeed, Inc. - WOLF
May 12, 2024 16:26 ET | Pomerantz LLP
NEW YORK, May 12, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Wolfspeed, Inc. (“Wolfspeed” or the “Company”) (NYSE: WOLF).   Such investors are advised...
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of XPEL, Inc. - XPEL
May 12, 2024 16:25 ET | Pomerantz LLP
NEW YORK, May 12, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  XPEL, Inc. (“XPEL” or the “Company”) (NASDAQ: XPEL). Such investors are advised to contact...
SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Akero Therapeutics, Inc. - AKRO
May 12, 2024 16:24 ET | Pomerantz LLP
NEW YORK, May 12, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Akero Therapeutics, Inc. (“Akero” or the “Company”) (NASDAQ: AKRO).   Such...
SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Compass Minerals International, Inc. – CMP
May 12, 2024 16:23 ET | Pomerantz LLP
NEW YORK, May 12, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Compass Minerals International, Inc. (“Compass” or the “Company”) (NYSE: CMP)....
SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Malibu Boats, Inc. – MBUU
May 12, 2024 16:22 ET | Pomerantz LLP
NEW YORK, May 12, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Malibu Boats, Inc. (“Malibu Boats” or the “Company”) (NASDAQ: MBUU). Such...
SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against AST SpaceMobile, Inc. – ASTS
May 12, 2024 16:21 ET | Pomerantz LLP
NEW YORK, May 12, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against AST SpaceMobile, Inc. (“AST” or the “Company”) (NASDAQ: ASTS). Such investors...
SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Autodesk, Inc. - ADSK
May 12, 2024 16:18 ET | Pomerantz LLP
NEW YORK, May 12, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Autodesk, Inc. (“Autodesk” or the “Company”) (NASDAQ: ADSK). Such investors are...